← back to search

Jianxiang Song

Nantong University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer research, Biology, Medicine, Carcinogenesis, Cell growth, and Lung cancer.
h-index
citations
112
works
14
NIH funding
primary concept
email

Recent publications

Macrophage Polarisation in the Tumour Microenvironment: Recent Research Advances and Therapeutic Potential of Different Macrophage Reprogramming
Cancer Control 2025cited by 19position: lastdoi
Multifaceted regulatory mechanisms of the EGR family in tumours and prospects for therapeutic applications (Review)
International Journal of Molecular Medicine 2025cited by 8position: lastdoi
The multiple biological activities of hyperoside: from molecular mechanisms to therapeutic perspectives in neoplastic and non-neoplastic diseases
Frontiers in Pharmacology 2025cited by 7position: lastdoi
Expression of ORMDL1 in esophageal squamous cell carcinoma and its effect on patient outcomes: A potential biomarker and treatment target
Translational Oncology 2025cited by 2position: lastdoi
KCNIP2: A key regulator in cardiac electrophysiology and tumorigenesis
Gene 2025cited by 2position: lastdoi
Progress, pharmacokinetics and future perspectives of luteolin modulating signaling pathways to exert anticancer effects: A review
Medicine 2024cited by 12position: lastdoi
LINC01133 regulates MARCKS expression via sponging miR-30d-5p to promote the development of lung squamous cell carcinoma
Translational Oncology 2024cited by 4position: middledoi
Mechanisms of Action of HSP110 and Its Cognate Family Members in Carcinogenesis
OncoTargets and Therapy 2024cited by 3position: lastdoi
Over‐expression of USP15/MMP3 predict poor prognosis and promote growth, migration in non-small cell lung cancer cells
Cancer Genetics 2023cited by 15position: middledoi
Pancancer analysis of the correlations of HS6ST2 with prognosis, tumor immunity, and drug resistance
Scientific Reports 2023cited by 4position: middledoi
Estrogen Sulfotransferase SULT1E1 Expression Levels and RegulatedFactors in Malignant Tumours
Protein and Peptide Letters 2023cited by 3position: lastdoi
NUF2 Is a Potential Immunological and Prognostic Marker for Non-Small-Cell Lung Cancer
Journal of Immunology Research 2022cited by 8position: middledoi
LncRNA MTX2-6 Suppresses Cell Proliferation by Acting as ceRNA of miR-574-5p to Accumulate SMAD4 in Esophageal Squamous Cell Carcinoma
Frontiers in Cell and Developmental Biology 2021cited by 14position: middledoi
LINC00518 Promotes Cell Proliferation by Regulating the Cell Cycle of Lung Adenocarcinoma Through miR-185-3p Targeting MECP2
Frontiers in Oncology 2021cited by 11position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rongqi Guo · Nantong University7 papers (2024–2025)Yangyang Li · Army Medical University6 papers (2024–2025)Rui Wang · Guangzhou University of Chinese Medicine6 papers (2023–2025)Yihao Wang · Nantong University6 papers (2024–2025)Jixiang Wu · Nantong University6 papers (2021–2024)Xia Li · Affiliated Hospital of Nantong University4 papers (2024–2025)Weisong Zhang · Nantong University4 papers (2024–2025)Hui‐Wen Chang · Utrecht University3 papers (2021–2024)ZhongQuan Yi · Nantong University3 papers (2022–2025)Yajun Zhang · University of Virginia3 papers (2021–2024)Zhan Shi · Jiangsu University3 papers (2021–2024)Weisong Zhang · Nantong University3 papers (2025–2025)Daguang Ni · Nantong University2 papers (2023–2023)Ming Liu · Yangtze University2 papers (2021–2024)Weiwei Chen · University of Leicester2 papers (2023–2023)Xia Li · Beijing Shijitan Hospital2 papers (2023–2025)Youqin Jiang · Nantong University2 papers (2023–2023)Hao Wang · Nantong University2 papers (2024–2025)Woda Shi · Fudan University2 papers (2023–2024)Wenyu Shi · Nantong University2 papers (2023–2023)